èšåºæ®µéã®ãã€ãªãã¯ãããžãŒäŒæ¥ã§ãã Aptevo Therapeutics Inc. ã¯ãç±³åœã§ããŸããŸãªçš®é¡ã®ããã®æ²»çã«å
ç«çæ³ã®åè£è¬ã®éçºã«éç¹ã眮ããŠããŸããäž»ãªèšåºåè£è¬ã¯ APVO436 ã§ãæ¥æ§éªšé«æ§çœè¡ç
ããã³éªšé«ç°åœ¢æçå矀ã«å¯Ÿãã第 1/1b çžèšåºè©Šéšãè¡ãããŠããäºéç¹ç°æ§ T 现èèªå°æäœåè£ã§ããå瀟ã®åèšåºåè£è¬ã«ã¯ã4-1BB (CD137) ããã³ããŸããŸãªçš®é¡ã®ããã§çºçŸããè
«çæå 5T4 ãæšçãšããäœçšæ©åºãç¹åŸŽãšããæ²»éšäžã®äºéç¹ç°æ§ ADAPTIR åè£è¬ ALG.APV-527ãããã³ 4-1BB ããã³ OX40 ãæšçãšãããã¥ã¢ã«ã¢ãŽãã¹ãäºéç¹ç°æ§æäœ APVO603 ããããŸãããŸããåç«è
ºããã®æ²»çã«ãã㊠PSMA éœæ§è
«çãžã®è¬å€ã®çäœå
ååžãé«ãã ADAPTIR-FLEX ãã©ãããã©ãŒã æè¡ã«åºã¥ãäºéç¹ç°æ§åè£è¬ APVO442 ãéçºäžã§ããããã³è¡æ¶²ããã³åºåœ¢è
«çã«éç¹ã眮ãããã®ä»ã®åèšåºéçºæ®µéã®æ²»çè¬ã補é ããŠããŸããå瀟ã¯ãALG.APV-527 ã®éçºã«é¢ã㊠Alligator Bioscience AB ãšææºããã³ãªãã·ã§ã³å¥çŽãçµãã§ããŸããAptevo Therapeutics Inc. 㯠2016 幎ã«èšç«ãããã¯ã·ã³ãã³å·ã·ã¢ãã«ã«æ¬ç€Ÿã眮ããŠããŸãã